For acute decompensated heart failure, which therapy is commonly used?

For acute decompensated heart failure, which therapy is commonly used?

• A. ACE inhibitors alone
• B. Nitroglycerin with BiPAP and furosemide
• C. Beta-blockers alone
• D. Digoxin monotherapy

Answer: (B)

In acute decompensated heart failure with pulmonary edema, the priority is rapid relief of congestion and improved oxygenation. The most effective approach combines reducing preload, removing excess fluid, and supporting breathing. Nitroglycerin acts as a potent venodilator, lowering venous return and left-sided filling pressures, which quickly eases pulmonary edema and dyspnea. Furosemide accelerates diuresis to drop overall fluid overload and further decrease filling pressures. BiPAP provides noninvasive positive-pressure ventilation, improving oxygenation and decreasing work of breathing, which can reduce the need for intubation. Together, this trio directly addresses the hemodynamic and respiratory problems of acute decompensation. ACE inhibitors alone don’t rapidly correct the acute congestion and can cause hypotension in unstable patients. Beta-blockers acutely reduce heart contractility and heart rate, potentially worsening the situation. Digoxin alone doesn’t provide the fast relief of edema or respiratory distress needed in the acute setting.

In acute decompensated heart failure with pulmonary edema, the priority is rapid relief of congestion and improved oxygenation. The most effective approach combines reducing preload, removing excess fluid, and supporting breathing. Nitroglycerin acts as a potent venodilator, lowering venous return and left-sided filling pressures, which quickly eases pulmonary edema and dyspnea. Furosemide accelerates diuresis to drop overall fluid overload and further decrease filling pressures. BiPAP provides noninvasive positive-pressure ventilation, improving oxygenation and decreasing work of breathing, which can reduce the need for intubation. Together, this trio directly addresses the hemodynamic and respiratory problems of acute decompensation.

ACE inhibitors alone don’t rapidly correct the acute congestion and can cause hypotension in unstable patients. Beta-blockers acutely reduce heart contractility and heart rate, potentially worsening the situation. Digoxin alone doesn’t provide the fast relief of edema or respiratory distress needed in the acute setting.